374 related articles for article (PubMed ID: 23981126)
1. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
Johnston IM; Nolan JD; Pattni SS; Appleby RN; Zhang JH; Kennie SL; Madhan GK; Jameie-Oskooei S; Pathmasrirengam S; Lin J; Hong A; Dixon PH; Williamson C; Walters JR
Am J Gastroenterol; 2016 Mar; 111(3):423-32. PubMed ID: 26856750
[TBL] [Abstract][Full Text] [Related]
3. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
Walters JR; Tasleem AM; Omer OS; Brydon WG; Dew T; le Roux CW
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test.
Borup C; Wildt S; Rumessen J; Graff J; Bouchelouche PN; Andersen TB; Vinter-Jensen L; Zaremba A; German Jørgensen SP; Gregersen T; Nøjgaard C; Timm HB; Rainteau D; Gauliard E; Munck LK
Am J Gastroenterol; 2020 Dec; 115(12):2086-2094. PubMed ID: 32740083
[TBL] [Abstract][Full Text] [Related]
5. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea.
Brydon WG; Nyhlin H; Eastwood MA; Merrick MV
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):117-23. PubMed ID: 8723414
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.
Borup C; Syversen C; Bouchelouche P; Damgaard M; Graff J; Rumessen JJ; Munck LK
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1399-402. PubMed ID: 26426834
[TBL] [Abstract][Full Text] [Related]
7.
Mena Bares LM; Carmona Asenjo E; García Sánchez MV; Moreno Ortega E; Maza Muret FR; Guiote Moreno MV; Santos Bueno AM; Iglesias Flores E; Benítez Cantero JM; Vallejo Casas JA
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):37-47. PubMed ID: 27765536
[TBL] [Abstract][Full Text] [Related]
8. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
Borup C; Wildt S; Rumessen JJ; Bouchelouche PN; Graff J; Damgaard M; McQuitty C; Rainteau D; Munck LK
Aliment Pharmacol Ther; 2017 Jun; 45(11):1433-1442. PubMed ID: 28378364
[TBL] [Abstract][Full Text] [Related]
9. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.
Walters JR; Johnston IM; Nolan JD; Vassie C; Pruzanski ME; Shapiro DA
Aliment Pharmacol Ther; 2015 Jan; 41(1):54-64. PubMed ID: 25329562
[TBL] [Abstract][Full Text] [Related]
10. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
[TBL] [Abstract][Full Text] [Related]
13. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
[TBL] [Abstract][Full Text] [Related]
14. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test.
Eusufzai S; Axelson M; Angelin B; Einarsson K
Gut; 1993 May; 34(5):698-701. PubMed ID: 8504974
[TBL] [Abstract][Full Text] [Related]
15. Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.
Appleby RN; Bajor A; Gillberg PG; Graffner H; Simrén M; Ung KA; Walters J
United European Gastroenterol J; 2017 Apr; 5(3):380-388. PubMed ID: 28507750
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.
Pattni SS; Brydon WG; Dew T; Walters JR
Clin Transl Gastroenterol; 2012 Jul; 3(7):e18. PubMed ID: 23238290
[TBL] [Abstract][Full Text] [Related]
17. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictive factors for positive
Murray IA; Murray LK; Woolson KL; Sherfi H; Dixon I; Palmer J; Sulkin T
Scand J Gastroenterol; 2017; 52(6-7):698-703. PubMed ID: 28276822
[TBL] [Abstract][Full Text] [Related]
19. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
Walters JR
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):561-7. PubMed ID: 20932141
[TBL] [Abstract][Full Text] [Related]
20. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
Borghede MK; Schlütter JM; Agnholt JS; Christensen LA; Gormsen LC; Dahlerup JF
Eur J Intern Med; 2011 Dec; 22(6):e137-40. PubMed ID: 22075299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]